Teladoc Health (TDOC) Price to Sales (2015 - 2026)

Teladoc Health has disclosed Price to Sales across 12 years of filings, most recently posting 2.54 for Q2 2026.

• In Q2 2026, Price to Sales rose 4.26% year-over-year to 2.54; the TTM figure through Jun 2026 stood at 0.62 (up 2.26% YoY), while the FY2025 annual figure was 0.49, down 19.57% from the prior year.
• Price to Sales came in at 2.54 for Q2 2026 at Teladoc Health, up from 1.6 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 20.6 in Q1 2022 to a low of 1.6 in Q1 2026.
• Average Price to Sales over 5 years is 5.01, with a median of 3.28 recorded in 2024.
• Year-over-year, Price to Sales tumbled 82.78% in 2022 and gained 4.26% in 2026.
• Over 5 years, Price to Sales stood at 6.04 in 2022, then fell by 9.96% to 5.44 in 2023, then plunged by 54.74% to 2.46 in 2024, then retreated by 21.03% to 1.94 in 2025, then jumped by 30.59% to 2.54 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 2.54 in Q2 2026, 1.6 in Q1 2026, and 1.94 in Q4 2025.